RxHub Triggers Antitrust Complaints From NCPA; FTC Sounds Interested
Executive Summary
The Federal Trade Commission may look into the Internet-based patient drug benefit exchange RxHub in response to complaints from retail pharmacy that the business is anticompetitive.
You may also be interested in...
PBM Medicare Role Should Be Administrative Only, Pharmacy Groups Tell HHS
PBM involvement in a Medicare prescription drug benefit should be limited to an administrative role, a coalition of eight pharmacy groups told HHS Secretary Thompson during a recent meeting.
First DataBank Must Create Integratable Data Files Competitor, FTC Says
First DataBank would be required to set up a competitor in the integratable drug data file market under an April 4 FTC complaint regarding the 1998 acquisition of Medi-Span by Hearst, which also owns First DataBank.
PBM-Sponsored RxHub Being Built To Centralize Patient Drug Benefit Data
AdvancePCS, Merck-Medco and Express Scripts' Internet-based patient drug benefit exchange RxHub is designed to increase PBM control over physician prescribing choices by bringing together information from different providers at one Web address.